- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 207/26 - 2-Pyrrolidones
Patent holdings for IPC class C07D 207/26
Total number of patents in this class: 308
10-year publication summary
|
22
|
16
|
20
|
16
|
15
|
20
|
18
|
20
|
8
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| University of Southern California | 2127 |
14 |
| Novartis AG | 10494 |
10 |
| Cayman Chemical Company, Incorporated | 66 |
10 |
| Pfizer Inc. | 3384 |
8 |
| BASF SE | 21135 |
7 |
| Servier Pharmaceuticals, LLC | 110 |
6 |
| Glaxosmithkline Intellectual Property Development Limited | 767 |
5 |
| California Institute of Technology | 4006 |
5 |
| Theravance Biopharma R&D IP, LLC | 442 |
5 |
| Pardes Biosciences, Inc. | 21 |
5 |
| Takeda Pharmaceutical Company Limited | 2710 |
4 |
| Purdue Research Foundation | 3776 |
4 |
| FMC Corporation | 820 |
4 |
| OPKO Health, Inc. | 45 |
4 |
| PTC Therapeutics, Inc. | 487 |
4 |
| Richter Gedeon Nyrt. | 1629 |
4 |
| The Scripps Research Institute | 1343 |
4 |
| Yale University | 2461 |
4 |
| Corteva Agriscience LLC | 2663 |
4 |
| Bristol-myers Squibb Company | 4795 |
3 |
| Other owners | 194 |